Fermentalg SA (FR:ALGAE)

:ALGAE

ALGAE

Fermentalg SA

RESEARCH TOOLSreports

Want to see FR:ALGAE full AI Analyst Report?

Fermentalg SA (ALGAE) Price & Analysis

5 Followers

ALGAE Stock Chart & Stats

€0.43

-€0.01(-2.61%)

At close: Jan 08 4:00 PM EST

€0.43

-€0.01(-2.61%)

Day’s Range― - ―

52-Week Range€0.40 - €0.64

Previous CloseN/A

Volume250.73K

Average Volume (3M)224.33K

Market Cap

€55.24M

Enterprise Value€45.19M

Total Cash (Recent Filing)€6.62M

Total Debt (Recent Filing)€5.02M

Price to Earnings (P/E)―

Beta1.04

Next Earnings

Oct 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.09

Shares Outstanding113,570,080

10 Day Avg. Volume242,064

30 Day Avg. Volume224,333

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)1.78

Price to Sales (P/S)3.34

P/FCF Ratio-5.50

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.08

Revenue Forecast (FY)€19.55M

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained multi-year revenue expansion indicates growing commercial traction for microalgae ingredients. This steady top-line growth supports scaling manufacturing, improves pricing leverage with customers, and underpins the potential to absorb fixed costs as the business matures.

Improving Gross MarginA move from negative to ~17% gross margin signals improving unit economics from process or product mix gains. Durable margin improvement is a prerequisite for eventual operating profitability and suggests the company is making structural progress on production efficiency.

Low LeverageReduced leverage lowers financial risk and interest burden, giving management flexibility to fund industrial scale-up or strategic partnerships. A conservative capital structure is valuable for a cash-burning biotech while it pursues commercialization.

Bears Say

Worsening Cash BurnPersistently negative operating and free cash flows, and material deterioration in 2025, create ongoing funding needs. That constrains reinvestment, risks dilution from capital raises, and limits runway for scaling manufacturing or entering new markets without external financing.

Large Net LossesDeep negative net margins indicate the core business still fails to cover operating costs. Unless cost structure or revenue mix changes materially, losses will persist, eroding returns and making it difficult to achieve sustainable profitability even if revenue continues to grow.

Erosion Of EquityDeclining shareholders' equity and highly negative ROE reflect accumulated losses and reduced capital cushions. This weakens the balance sheet, narrows strategic options, and increases sensitivity to funding shocks or slower sales execution over the medium term.

ALGAE FAQ

What was Fermentalg SA’s price range in the past 12 months?

Fermentalg SA lowest stock price was €0.40 and its highest was €0.64 in the past 12 months.

What is Fermentalg SA’s market cap?

Fermentalg SA’s market cap is €55.24M.

When is Fermentalg SA’s upcoming earnings report date?

Fermentalg SA’s upcoming earnings report date is Oct 06, 2026 which is in 138 days.

How were Fermentalg SA’s earnings last quarter?

Fermentalg SA released its earnings results on Apr 02, 2026. The company reported -€0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.053.

Is Fermentalg SA overvalued?

According to Wall Street analysts Fermentalg SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fermentalg SA pay dividends?

Fermentalg SA does not currently pay dividends.

What is Fermentalg SA’s EPS estimate?

Fermentalg SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fermentalg SA have?

Fermentalg SA has 113,570,080 shares outstanding.

What happened to Fermentalg SA’s price movement after its last earnings report?

Fermentalg SA reported an EPS of -€0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.724%.

Which hedge fund is a major shareholder of Fermentalg SA?

Currently, no hedge funds are holding shares in FR:ALGAE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Fermentalg SA

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.